PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAkcea Therapeutics
Akcea Therapeutics(AKCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
TegsediInotersen2018-10-052025-2031
Amyloidosis
,
Familial amyloid neuropathies
WaylivraVolanesorsen2019-05-03
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Volanesorsen
cardiovascular abnormalities
,
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemias
,
lipodystrophy
,
familial partial lipodystrophy
,
hypertriglyceridemia
Inotersen
cardiomyopathies
,
polyneuropathies
,
amyloid neuropathies
,
amyloidosis
,
familial amyloid neuropathies
,
alzheimer disease
,
immunoglobulin light-chain amyloidosis
,
pregnancy
,
familial amyloidosis
Pelacarsen
renal insufficiency
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
VUPANORSEN
hypertriglyceridemia
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
lipodystrophy
,
familial partial lipodystrophy
,
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
fatty liver
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemia type i
,
hyperlipoproteinemias
,
homozygous familial hypercholesterolemia
Endocrine
healthy volunteers/patients
,
ovarian neoplasms
,
triple negative breast neoplasms
,
castration-resistant prostatic neoplasms
,
non-small-cell lung carcinoma
,
liposarcoma
,
colorectal neoplasms
,
adenocarcinoma of lung
,
lobular carcinoma
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
neoplasms
,
type 2 diabetes mellitus
,
prostatic neoplasms
,
endocrine system diseases
,
diabetes mellitus
,
male breast neoplasms
,
recurrence
,
unilateral breast neoplasms
,
obesity
,
glucose metabolism disorders
,
metabolic diseases
,
body weight
,
overweight
,
nutrition disorders
,
signs and symptoms
,
nutritional and metabolic diseases
,
signs and symptoms pathological conditions
,
overnutrition
,
neoplasm metastasis
,
breast neoplasms
,
acromegaly
,
laron syndrome
,
pituitary dwarfism
,
left ventricular hypertrophy
,
left ventricular dysfunction
,
bipolar disorder
,
coronary disease
,
coronary artery disease
,
chronic disease
,
traumatic brain injuries
,
brain concussion
,
hypopituitarism
Trinessa
healthy volunteers/patients
,
hypertension
Fluoroquinolone
healthy volunteers/patients
,
hypertension
Thienopyridine
healthy volunteers/patients
,
therapeutic equivalency
,
cardiovascular diseases
,
percutaneous coronary intervention
,
thrombosis
,
stroke
,
intracranial arteriosclerosis
,
coronary artery disease
,
coronary disease
,
myocardial ischemia
,
acute coronary syndrome
,
syndrome
,
diabetes mellitus
,
myocardial infarction
,
type 2 diabetes mellitus
,
infarction
,
inflammation
,
peripheral arterial disease
,
heart diseases
,
retinal diseases
,
inferior wall myocardial infarction
,
no-reflow phenomenon
,
vascular diseases
,
arterial occlusive diseases
,
intermittent claudication
,
ankle brachial index
,
atherosclerotic plaque
,
acute kidney injury
,
liver failure
,
acute liver failure
,
dyspnea
Tqj230
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use